在2级脑膜瘤中,NF2功能丧失和缺氧驱动辐射抵抗
Bhuvic Patel1,2, Sangami Pugazenthi1, Collin W English3
1Department of Neurological Surgery, Washington University School of Medicine, St Louis, MO, USA.
Journal of the National Cancer Institute
|January 31, 2025
概括
世界卫生组织第二级脑膜瘤中的NF2功能丧失突变,特别是缺氧,通过改变细胞亡和增殖途径来驱动辐射抵抗,影响局部控制.
科学领域:
- 神经瘤学神经瘤学
- 辐射瘤学 辐射瘤学
- 癌症基因组学 癌症基因组学
背景情况:
- 世界卫生组织第2级脑膜瘤 (G2Ms) 经常复发并抵抗治疗.
- 在G2M中死亡与放射治疗后局部控制较差相关,但根本机制尚不清楚.
研究的目的:
- 调查G2Ms中辐射抵抗的驱动因素和生物标志物.
- 了解基因突变 (NF2) 和微环境因素 (低氧) 在辐射反应中的作用.
主要方法:
- 对113个G2Ms进行基因测序和组织病理学分析.
- 在电离辐射后克隆基因生存的体外研究.
- 大量和单核RNA测序G2M瘤和模型.
主要成果:
- NF2功能丧失突变与亡和辐射后局部控制的恶化有关.
- 在低氧条件下,NF2倒置在体外增加了辐射抵抗.
- 一个50基因的签名确定了耐辐射的G2Ms,NF2-突变/死瘤显示了减少的亡和增加的增殖.
结论:
- 与低氧相结合的NF2功能丧失通过转录性变化赋予了辐射抵抗.
- 这些发现确定了潜在的生物标志物和治疗点,以改善抗辐射G2Ms的局部控制.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
11:45Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition
Published on: November 14, 2013
12.1K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
